findmyKOL

Michael Fried, MD

Enriched profile

Professor of Medicine and Director, UNC Liver Center, Division of Gastroenterology and Hepatology, UNC School of Medicine · University of North Carolina at Chapel Hill

ORCIDNone on fileNPI
Region🇺🇸 Chapel Hill, NC · Southeast · United StatesSpecialtyGastroenterologyFocusViral Hepatitis (B/C)+1
Last active 2023findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationNone indexedOnline presenceverified 2026Payments2023–2023NIH funding1999–2019Why? →

Michael Fried is Professor of Medicine and Director, UNC Liver Center, Division of Gastroenterology and Hepatology, UNC School of Medicine at University of North Carolina at Chapel Hill. ClinicalTrials.gov lists 11 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 31 Aug 2026

Michael W. Fried, MD, is Professor of Medicine and Director, UNC Liver Center, Division of Gastroenterology and Hepatology, UNC School of Medicine at University of North Carolina at Chapel Hill, School of Medicine (Division of Gastroenterology and Hepatology). The public record shows 818 publications with 42,728 citations (h-index 97), centered on Viral Hepatitis (B/C), NASH / NAFLD / MASH. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 1 companies, 7 NIH-funded awards (1999–2019).

  • Top research focus: Viral Hepatitis (B/C)
  • 11 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 31 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Viral Hepatitis (B/C)6 trialsHepatitis C5 trialsFatty Liver2 trialsFatty Liver, Alcoholic2 trialsHepatitis C, Chronic2 trialsHepatitis, Chronic2 trialsHemophilia A1 trialNon-alcoholic Fatty Liver Disease1 trialNASH / NAFLD / MASH1 trialObesity1 trialAnorexia Nervosa1 trialAnorexia1 trialHepatitis B1 trialEsophageal Motility Disorders1 trial

Research focus

OpenAlex concept fingerprint
Viral Hepatitis (B/C)NASH / NAFLD / MASH

Drugs & molecules

across trials, industry payments and publications
Ocalivageneric · Obeticholic acidClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
University of North Carolina, Chapel HillClinical trials4Industry paymentsUniversity of ZurichClinical trials3Industry paymentsNational Center for Complementary and Integrative Health (NCCIH)Clinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
97h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
11clinical trials

Investigator role on registered studies.

View trials
1companies · 2023–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments
7NIH grants · 1999–2019

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 31 Aug 2026

Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 31 Aug 2026

1 company reported payments to CMS in program years 2023–2023. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    84.9%
    Nucleoside and nucleotide reverse transcriptase inhibitors53.4%
    Vemlidy100%
    Part D<11 patients
    Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor31.5%
    Entecavir100%
    Part D<11 patients
  • Metabolism & gastrointestinal

    15.1%
    Bile Acid15.1%
    Ursodiol100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 31 Aug 2026

7 NIH research awards on record, funded 19992019 per NIH RePORTER. The latest:

95 more award records behind the reveal.Reveal →

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 31 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/michael-fried-md-16546625

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com

Mentions by others

where others cite or feature them

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 31 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Fellowship

    Gastroenterology, SUNY Health Science Center at Syracuse; Medical Staff Fellow (viral hepatitis), National Institutes of Health, Bethesda, MD

    1993
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
  • B.A.

    Cornell University (undergraduate)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
  • M.D.

    Tel Aviv University

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
  • Residency

    Internal Medicine, SUNY Health Science Center at Syracuse

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
  • FAASLD - Fellow

    American Association for the Study of Liver Diseases

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu

Editorial & leadership roles

journal and society appointments
  • President

    American Association for the Study of Liver Diseases (AASLD), 2019 term

    2019
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →journals.lww.com
  • Director

    UNC Liver Center

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
  • Co-Chair

    NIH/NIDDK Hepatitis B Research Network (HBRN)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu
2 more roles behind the reveal.Reveal →

Awards & honors

honors on the public record
  • FDA Excellence in Regulatory Science Award

    awarded to the HCV-TARGET team (co-PI) for contributions to optimizing hepatitis C patient management

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →med.unc.edu

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.